← FDA Drug Approvals (Drugs@FDA)

RISPERIDONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL MOLECULAR · Approved 2015-01-12

Drug application

FDA Application #

ANDA202386

Application type

Abbreviated New Drug Application (Generic)

Brand name

RISPERIDONE

Generic name

RISPERIDONE

Active ingredients

RISPERIDONE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

CHARTWELL MOLECULAR

Manufacturer

Chartwell RX, LLC

First approval

2015-01-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown